









Markets
/
Stocks
/
nasdaq-drts
/

Alpha Tau Medical Ltd

DRTS

5.080USD

-0.020-0.39%

Close 12/23, 16:00（ET）Quotes delayed by 15 min

433.14MMarket Cap

LossP/E TTM



Alpha Tau Medical Ltd

5.080

-0.020-0.39%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Cash Flow Statement

You can access the annual and quarterly cash flow statements of Alpha Tau Medical Ltd to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2022Q2

FY2022Q1

FY2021Q2

FY2021Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-290.49%-8.74M

-110.52%-6.58M

---2.24M

---3.13M

Net income from continuing operations

71.37%-2.00M

-119.83%-25.74M

---6.98M

---11.71M

Operating gains losses

29.10%244.00K

40.85%231.00K

--189.00K

--164.00K

Other non-cash items

-256.54%-5.81M

99.85%16.91M

--3.71M

--8.46M

Change in working capital

-422.05%-2.51M

99.85%-1.00K

--780.00K

---667.00K

-Change in prepaid expenses

220.75%1.02M

-387.24%-1.64M

--318.00K

---337.00K

-Change in payables and accrued expense

-787.02%-900.00K

-145.02%-985.00K

--131.00K

---402.00K

Cash from non-recurring investing activities

Cash from operating activities

-290.49%-8.74M

-110.52%-6.58M

---2.24M

---3.13M

Investing cash flow

Net cash from continuing investing activities

-36.96%377.00K

-51.07%298.00K

--598.00K

--609.00K

Capital expenditures

-36.96%377.00K

-51.07%298.00K

--598.00K

--609.00K

Net cash flow from disposal of fixed assets

-36.96%377.00K

-51.07%298.00K

--598.00K

--609.00K

Net cash flow from investment products

-3780.00%-92.00M

----

--2.50M

----

Cash from non-current investing activities

Net cash flow from investing activities

-4956.83%-92.38M

51.07%-298.00K

--1.90M

---609.00K

Financing cash flow

Cash flow from continuous financing activities

73975.00%14.81M

8198400.00%81.98M

--20.00K

--1.00K

Proceeds from stock option exercised by employees

-100.00%0.00

--20.00K

--1.00K

Proceeds from issuance of warrants

--1.91M

--1.35M

--0.00

Net cash flow from other financing activities

--12.91M

--80.64M

----

--0.00

Net cash from non-recurrent financing activities

Net cash from financing activities

73975.00%14.81M

8198400.00%81.98M

--20.00K

--1.00K

Net cash flow

Beginning cash balance

732.98%98.91M

47.48%23.85M

--11.87M

--16.17M

Current period cash flow changes

-54675.32%-86.55M

1845.44%75.05M

---158.00K

---4.30M

Effect of exchange rate changes

-250.94%-240.00K

91.49%-48.00K

--159.00K

---564.00K

Ending cash balance

5.52%12.36M

732.98%98.91M

--11.72M

--11.87M

Free cash flow

-221.47%-9.12M

-84.19%-6.88M

---2.84M

---3.74M

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

